FeaturedNeurologyNeuroscience·November 30, 2022·4 min readControversial Alzheimer’s Drug Approval Sparks Surprising ImpactMedia coverage of the FDA-approved Alzheimer's drug aducanumab made the public less willing to volunteer in Alzheimer's pharmaceutical trials.Read More
FeaturedNeurologyNeuroscience·June 7, 2021·3 min readFDA Grants Accelerated Approval for Alzheimer’s Drug – AduhelmAduhelm, a new drug that appears to reduce amyloid plaques in the brain, is the first new Alzheimer's disease medication to be approved since 2003, and is the first drug that targets the fundamental pathology of the disease.Read More
FeaturedNeurology·August 31, 2016·5 min readAntibody Reduces Harmful Amyloid Plaques in Alzheimer’s PatientsA newly developed antibody has shown to trigger a meaningful reduction of amyloid beta in patients with early stage Alzheimer's disease.Read More
